Literature DB >> 18835345

Permeation of quinine across sublingual mucosa, in vitro.

Charlene M Y Ong1, Charles M Heard.   

Abstract

Quinine is the first line treatment in severe P. falciparum malaria and nocturnal leg cramps and a fast, convenient delivery method of this drug quinine is needed. The purpose of this study was to investigate in vitro the sublingual route for the delivery of quinine. Permeation studies were carried out with Franz diffusion cells containing sublingual mucosa membranes with PBS receptor phase and dosed with solutions of quinine hydrochloride or quinine/2-hydroxypropyl-beta-cyclodextrin complexes. Receptor phase samples were taken 2 hourly over a 12h period and quinine was determined by reverse-phase HPLC analysis. The ventral surface of the tongue was significantly more permeable than porcine floor of the mouth (p<0.05) and there was no significant effect of freezing on the ventral surface of the tongue (p 0.2444). The presence of saliva caused a decrease in the permeation of quinine across the ventral surface of the tongue by up to 68%. Inclusion complexation between quinine and 2-HP-beta-CD was supported by (1)H NMR spectral data, and an ethanol vehicle provided the highest quinine flux from the inclusion complex solutions compared to deionised water and PEG. Overall, the data support further investigations into the clinical use of sublingual quinine, particularly for children with falciparum malaria or patients with nocturnal leg cramps. Use of quinine/cyclodextrin inclusion complexes may circumvent compliance issues due to bitter taste.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18835345     DOI: 10.1016/j.ijpharm.2008.08.048

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  3 in total

1.  Sublingual Diffusion of Epinephrine Microcrystals from Rapidly Disintegrating Tablets for the Potential First-Aid Treatment of Anaphylaxis: In Vitro and Ex Vivo Study.

Authors:  Mutasem M Rawas-Qalaji; Shima Werdy; Ousama Rachid; F Estelle R Simons; Keith J Simons
Journal:  AAPS PharmSciTech       Date:  2015-03-04       Impact factor: 3.246

2.  Optimum topical delivery of adrenergic agonists to oral mucosa vasculature.

Authors:  Cheryl M Soref; William E Fahl
Journal:  Pharm Res       Date:  2014-07-31       Impact factor: 4.200

3.  Sublingual Delivery of Frovatriptan: An Indication of Potential Alternative Route.

Authors:  Hitesh Verma; Surajpal Verma; Shyam Baboo Prasad; Harmanpreet Singh
Journal:  Int Sch Res Notices       Date:  2014-10-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.